Pagosid®
Natural health product licensed in Canada
- Licence holder
- Flora Manufacturing & Distributing Ltd
- NPN or DIN-HM
- 80003594
- Status
- Active licence
- Licence date
- 15 June 2007
- Revision date
- Not provided
- Form
- Comprimé
- Route of administration
- Orale
- Application type
- Officinale
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
Medicinal composition not provided.
Non-medicinal ingredients
Amidon de maïs, Cellulose en poudre, Stéarate de calcium, Carboxyméthylcellulose de sodium, Povidone, Talc, Dioxyde de silicium, Poly(butyl methacrylate, (2-dimethyl aminoethyl)methyacrylate, methyl methacrylate), Lactose monohydrate
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 3 Comprimé | 3 Tous les jours |
Uses authorised in Canada
Traditionally used to help treat inflammation of the joints.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Consult a health care practitioner prior to use if you have heart disease, if you are taking antiarrhythmic medication and/or blood thinners, if you are diabetic, if sysmptoms persist after 6 months. Discontinue if you experience prolonged gastrointestinal discomfort. Blister package for your protection-do not use if the peak is damaged.
Source
Official Health Canada record, licence 80003594
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.